Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01036711 · ClinicalTrials.gov registry record
Effects of Nicotine on Cognitive Task Performance and Brain Activity as Measured by fMRI
A clinical trial, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- 249
- Enrollment target
NCT01036711: Completed study, sponsored by National Institute on Drug Abuse (NIDA).
NCT01036711 is a clinical trial that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 249 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01036711 has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- 249 participants
- Enrollment target
Study Summary
Background: \- Many cigarette smokers claim that smoking improves their ability to think and concentrate, and have reported problems in thinking and concentration after quitting smoking. Some research has indicated that nicotine can enhance certain aspects of attention and memory in humans. However, more research is needed to determine how nicotine affects different elements of the brain s ability to think, pay attention, respond to rewards, and make decisions. Researchers are interested in using functional magnetic resonance imaging (fMRI) to study the effects of nicotine on brain function and activity. Objectives: \- To determine the effects of nicotine on attentional and other thinking processes, including reward-seeking behavior. Eligibility: \- Individuals between 18 and 50 years of age who are either current smokers (10 or more cigarettes per day for at least 1 year) or nonsmokers. Design: * The study has four experiments. Each experiment requires two MRI scanning sessions and a training session. Participant can do one or all of the experiments. * Participants will receive training on the types of computerized tests that will be given during the active portion of the study. Participants will also fill out questionnaires on nicotine use and other alcohol and drug use, and provide breath and urine samples. * During the test sessions, participants will have fMRI scanning while performing up to four different sets of tasks that test attention, memory, concentration, reward-seeking behavior, and decision making. Smokers will wear a nicotine patch or placebo patch during the test sessions, but will not be told which patch they are receiving. The order of these sessions will be different for individual participants. * Participants will provide blood and urine samples throughout the research study for evaluation purposes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 249 participants |
| Start Date | 2002-09-17 |
| Est. Completion | 2012-11-26 |
What the finished NCT01036711 record still lists
NCT01036711 is an observational study that tracks outcomes without assigning an intervention. The registered 249 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01036711 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01036711 about?
NCT01036711 is a clinical study titled "Effects of Nicotine on Cognitive Task Performance and Brain Activity as Measured by fMRI". Background: \- Many cigarette smokers claim that smoking improves their ability to think and concentrate, and have reported problems in thinking and concentration after quitting smoking. Some research has indicated that nicotine can enhance certain aspects of attention and memory in humans. However...
What is the current status of trial NCT01036711?
This trial is currently completed. The enrollment target is 249 participants. The study started on 2002-09-17. Estimated completion is 2012-11-26.
Who is sponsoring clinical trial NCT01036711?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04628767 · 249 participants · Phase 2
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
- NCT05834907 · 249 participants · NA
Hands and Hearts Together
- NCT06067555 · 249 participants · Early Phase 1
Intradermal Influenza Vaccination
- NCT06588478 · 249 participants · Phase 2
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI